Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.6342
+0.0109 (1.75%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Unicycive Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Unicycive Therapeutics stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 7.50. The average target predicts an increase of 767.23% from the current stock price of 0.63.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $3.00 $5.50 $6.00 $7.50
Change +373.04% +767.23% +846.07% +1082.6%

Analyst Ratings

The average analyst rating for Unicycive Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 111112
Buy 333331
Hold 000000
Sell 000000
Strong Sell 000000
Total 444443

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Strong Buy
Initiates
$6
Strong Buy Initiates $6 +846.07% Apr 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7.5
Strong Buy Reiterates $7.5 +1,082.59% Apr 11, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$4$7.5
Strong Buy Maintains $4$7.5 +1,082.59% Apr 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +530.72% Jan 29, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$4
Strong Buy Maintains $4 +530.72% Jan 8, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
21.15M
Revenue Next Year
375.78M
from 21.15M
Increased by 1,677.16%
EPS This Year
-0.28
from -0.56
EPS Next Year
0.97
from -0.28
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
--951.00K675.00K-21.15M375.78M503.04M
Revenue Growth
----29.02%--1,677.16%33.87%
EPS
-0.27-0.86-1.20-1.28-0.56-0.280.972.01
EPS Growth
-------107.72%
Forward PE
------0.650.32
No. Analysts
-----876
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 45.7M 522.5M 1.2B
Avg 21.1M 375.8M 503.0M
Low 4.1M 234.4M 163.4M

Revenue Growth

Revenue Growth 20252026202720282029
High -
2,371.2%
218.0%
Avg -
1,677.2%
33.9%
Low -
1,008.5%
-56.5%

EPS Forecast

EPS 20252026202720282029
High 0.04 1.72 3.85
Avg -0.28 0.97 2.01
Low -0.42 0.43 0.26

EPS Growth

EPS Growth 20252026202720282029
High - -
297.7%
Avg - -
107.7%
Low - -
-72.7%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.